Extracorporeal membrane oxygenation for cardiac support

Giles J. Peek, Richard K. Firmin

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Extracorporeal membrane oxygenation (ECMO) uses cardiopulmonary bypass technology to provide prolonged cardiac or respiratory support in the intensive care unit. The use of ECMO for neonatal respiratory failure is now good evidence-based medicine following publication of the UK Collaborative ECMO Trial, but its use in adults and children remains controversial. In this review the use of ECMO to support paediatric patients with pre-and post-operative cardiac insufficiency is discussed. The survival with ECMO in these patients is 43-61%, which is remarkable in a group of patients who are moribund prior to initiation of ECMO.

Original languageEnglish (US)
Pages (from-to)371-388
Number of pages18
JournalCoronary Artery Disease
Volume8
Issue number6
StatePublished - 1997
Externally publishedYes

Fingerprint

Extracorporeal Membrane Oxygenation
Evidence-Based Medicine
Cardiopulmonary Bypass
Respiratory Insufficiency
Intensive Care Units
Publications
Pediatrics
Technology
Survival

Keywords

  • Cardiac failure
  • Cardiac surgery
  • ECMO
  • Intensive care
  • Paediatric

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Peek, G. J., & Firmin, R. K. (1997). Extracorporeal membrane oxygenation for cardiac support. Coronary Artery Disease, 8(6), 371-388.

Extracorporeal membrane oxygenation for cardiac support. / Peek, Giles J.; Firmin, Richard K.

In: Coronary Artery Disease, Vol. 8, No. 6, 1997, p. 371-388.

Research output: Contribution to journalReview article

Peek, GJ & Firmin, RK 1997, 'Extracorporeal membrane oxygenation for cardiac support', Coronary Artery Disease, vol. 8, no. 6, pp. 371-388.
Peek, Giles J. ; Firmin, Richard K. / Extracorporeal membrane oxygenation for cardiac support. In: Coronary Artery Disease. 1997 ; Vol. 8, No. 6. pp. 371-388.
@article{c1af02a1352e4026a55f17c9a434c4e9,
title = "Extracorporeal membrane oxygenation for cardiac support",
abstract = "Extracorporeal membrane oxygenation (ECMO) uses cardiopulmonary bypass technology to provide prolonged cardiac or respiratory support in the intensive care unit. The use of ECMO for neonatal respiratory failure is now good evidence-based medicine following publication of the UK Collaborative ECMO Trial, but its use in adults and children remains controversial. In this review the use of ECMO to support paediatric patients with pre-and post-operative cardiac insufficiency is discussed. The survival with ECMO in these patients is 43-61{\%}, which is remarkable in a group of patients who are moribund prior to initiation of ECMO.",
keywords = "Cardiac failure, Cardiac surgery, ECMO, Intensive care, Paediatric",
author = "Peek, {Giles J.} and Firmin, {Richard K.}",
year = "1997",
language = "English (US)",
volume = "8",
pages = "371--388",
journal = "Coronary Artery Disease",
issn = "0954-6928",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Extracorporeal membrane oxygenation for cardiac support

AU - Peek, Giles J.

AU - Firmin, Richard K.

PY - 1997

Y1 - 1997

N2 - Extracorporeal membrane oxygenation (ECMO) uses cardiopulmonary bypass technology to provide prolonged cardiac or respiratory support in the intensive care unit. The use of ECMO for neonatal respiratory failure is now good evidence-based medicine following publication of the UK Collaborative ECMO Trial, but its use in adults and children remains controversial. In this review the use of ECMO to support paediatric patients with pre-and post-operative cardiac insufficiency is discussed. The survival with ECMO in these patients is 43-61%, which is remarkable in a group of patients who are moribund prior to initiation of ECMO.

AB - Extracorporeal membrane oxygenation (ECMO) uses cardiopulmonary bypass technology to provide prolonged cardiac or respiratory support in the intensive care unit. The use of ECMO for neonatal respiratory failure is now good evidence-based medicine following publication of the UK Collaborative ECMO Trial, but its use in adults and children remains controversial. In this review the use of ECMO to support paediatric patients with pre-and post-operative cardiac insufficiency is discussed. The survival with ECMO in these patients is 43-61%, which is remarkable in a group of patients who are moribund prior to initiation of ECMO.

KW - Cardiac failure

KW - Cardiac surgery

KW - ECMO

KW - Intensive care

KW - Paediatric

UR - http://www.scopus.com/inward/record.url?scp=0030865625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030865625&partnerID=8YFLogxK

M3 - Review article

C2 - 9347217

AN - SCOPUS:0030865625

VL - 8

SP - 371

EP - 388

JO - Coronary Artery Disease

JF - Coronary Artery Disease

SN - 0954-6928

IS - 6

ER -